Neuronetics, Inc. - Common Stock (STIM)
3.2700
-0.1800 (-5.22%)
Neuronetics Inc is a medical technology company focused on developing non-invasive solutions for mental health disorders
Primarily, the company specializes in the innovation and commercialization of neuromodulation therapies, particularly transcranial magnetic stimulation (TMS). This advanced treatment aims to address conditions such as depression and anxiety by using magnetic fields to stimulate nerve cells in the brain, promoting improved mood and cognitive function in patients. Neuronetics is dedicated to expanding access to evidence-based treatments, enhancing the quality of life for individuals struggling with mental health issues.
Frequently Asked Questions
Is Neuronetics, Inc. - Common Stock publicly traded?
Yes, Neuronetics, Inc. - Common Stock is publicly traded.
What exchange does Neuronetics, Inc. - Common Stock trade on?
Neuronetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Neuronetics, Inc. - Common Stock?
The ticker symbol for Neuronetics, Inc. - Common Stock is STIM on the Nasdaq Stock Market
What is the current price of Neuronetics, Inc. - Common Stock?
The current price of Neuronetics, Inc. - Common Stock is 3.270
When was Neuronetics, Inc. - Common Stock last traded?
The last trade of Neuronetics, Inc. - Common Stock was at 4:00 pm EST on February 5th, 2025
What is the market capitalization of Neuronetics, Inc. - Common Stock?
The market capitalization of Neuronetics, Inc. - Common Stock is 99.24M
How many shares of Neuronetics, Inc. - Common Stock are outstanding?
Neuronetics, Inc. - Common Stock has 30.35M shares outstanding.